3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Terminated
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Classical hematology
1
CNS
1
Conditions
Multiple Myeloma
478
Neoplasms, Plasma Cell
102
Lymphoma
86
Lymphoma, Non-Hodgkin
75
Leukemia, Lymphocytic, Chronic, B-Cell
72
Myelodysplastic Syndromes
71
Recurrence
68
Leukemia, Myeloid, Acute
68
Leukemia
68
Precursor Cell Lymphoblastic Leukemia-Lymphoma
67
Hodgkin Disease
66
Lymphoma, Mantle-Cell
53
Lymphoma, Large B-Cell, Diffuse
53
Lymphoma, Follicular
45
Myeloproliferative Disorders
43
Neoplasms
41
Lymphoma, B-Cell, Marginal Zone
41
Burkitt Lymphoma
41
Primary Myelofibrosis
38
Lymphoma, Large-Cell, Immunoblastic
36
Lymphoma, T-Cell, Cutaneous
31
Leukemia, Myelomonocytic, Chronic
31
Sezary Syndrome
29
Mycosis Fungoides
29
Leukemia, Myeloid, Chronic-Phase
29
Leukemia, Myeloid, Accelerated Phase
29
Congenital Abnormalities
29
Leukemia, Hairy Cell
27
Blast Crisis
27
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
25
Interventions
ixazomib
1
Clinical Trials, Phase II as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Genetic Diseases, Inborn
×
Plasma cell
×
Clear all
NCT03683277
2025-02-19
IFM2014-01
Intergroupe Francophone du Myelome
Phase 2
Terminated
26 enrolled